APRE
Aprea Therapeutics Inc
NASDAQ: APRE · HEALTHCARE · BIOTECHNOLOGY
$0.82
-2.14% today
Updated 2026-04-29
Market cap
$9.81M
P/E ratio
—
P/S ratio
34.34x
EPS (TTM)
$-1.93
Dividend yield
—
52W range
$1 – $2
Volume
0.5M
Aprea Therapeutics Inc (APRE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+0.7%
Last 4 quarters
Revenue YoY growth
-98.4%
Most recent quarter
EPS YoY growth
+34.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-9.8%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-16 | $-0.32 | +11.1% | $0.74 | $0.78 | +6.3% |
| 2025-11-12 | $-0.47 | -67.9% | $1.32 | $1.19 | -9.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.36 | $-0.32 | +11.1% | $3337.00 | -98.4% |
| 2025-09-30 | $-0.28 | $-0.47 | -67.9% | $1848.00 | -99.5% |
| 2025-06-30 | $-0.71 | $-0.53 | +25.4% | $118111.00 | -79.0% |
| 2025-03-31 | $-1.00 | $-0.66 | +34.4% | $162463.00 | -57.3% |
| 2024-12-31 | $-0.54 | $-0.49 | +9.3% | $205817.00 | +1362.3% |
| 2024-09-30 | $-0.74 | $-0.64 | +13.5% | $354621.00 | +11.0% |
| 2024-06-30 | $-0.63 | $-0.58 | +7.9% | $561574.00 | +124.9% |
| 2024-03-31 | $-0.78 | $-0.67 | +14.1% | $380569.00 | — |
| 2023-12-31 | $-0.77 | $-0.92 | -19.5% | $14075.00 | — |
| 2023-09-30 | $-1.16 | $-0.86 | +25.9% | $319468.00 | — |
| 2023-06-30 | $-1.42 | $-0.87 | +38.7% | $249688.00 | — |
| 2023-03-31 | $-1.50 | $-1.34 | +10.7% | — | — |
Frequently asked questions
Has Aprea Therapeutics Inc beaten earnings estimates?
Aprea Therapeutics Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +0.7% over the last 4 quarters.
How does APRE stock react to earnings?
APRE stock has moved an average of -1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Aprea Therapeutics Inc's revenue growth rate?
Aprea Therapeutics Inc reported year-over-year revenue growth of -98.4% in its most recent quarter, with EPS growing +34.7% year-over-year.